On 25 October, the 2023 Annual Meeting and Third Technical Symposium of the National Standardisation Innovation Base (Dairy Industry) (NSID) convened in Beijing. Synaura was honoured with the JinLi Innovation Project award from the National Standardisation Innovation Base (Dairy Industry), fully demonstrating the company's outstanding capabilities in R&D innovation and industrial transformation within the field of biosynthetic technology. This recognition signifies Synaura's significant contribution to advancing standardisation and high-quality development within China's dairy industry.

Dairy Innovation: An Inevitable Trend

The National Technology Standards Innovation Base (Dairy Industry) (hereinafter referred to as the Dairy Innovation Base) serves as a platform to advance standardisation and technological innovation within the dairy sector. To implement the National Standardisation Development Outline and leverage the role of innovation bases, the Dairy Innovation Base has collaborated with the National Technical Committee for Food Industry Standardisation (SAC/TC64), the National Technical Committee for Food Quality Control and Management Standardisation (SAC/TC313), the National Working Group for Food Nutrition and Health Management Standardisation (SAC/SWG25), and the National Food Fermentation Standardisation Centre. This initiative aims to showcase and promote advanced innovative technologies and standards within the industry, thereby enhancing the level of technological and standard innovation in the dairy sector and driving the high-quality development of China's dairy industry.

Synaura Secures Further Accolade

Synaura's project proposal, ‘Microbial Fermentation Method for Preparing 2'-Fucosyllactose (2'-FL) and Its Industrial Applications,’ has been honoured with the JinLi Innovation Project award. This recognition follows the project's outstanding innovation capabilities and industrial achievements, having successfully navigated three rounds of rigorous evaluation: formal review, expert correspondence assessment, and expert panel review (including defence). Ultimately, it distinguished itself among 73 competing proposals to claim this prestigious distinction.

Synaura Biotech is a nationally leading bio-manufacturing enterprise possessing advanced synthetic biology technologies. The company specialises in developing synthetic biology methodologies and applying them to large-scale production. Presently, Synaura Biotech has established an extensive biological resource engineering library platform, accumulating substantial expertise in biosynthesis, intelligent design of high-performance cell factories, and scaled-up product manufacturing. Synaura Biotech remains committed to driving innovation and advancement in biotechnology, delivering premium products and services to global clients.

Pioneering Innovation, Leading the Way

Synaura's recent award of the JinLi Innovation Project Certificate from the National Technical Standards Innovation Base (Dairy Sector) represents not only the highest recognition of our company's outstanding achievements in HMO product R&D and industrial application, but also a commendation of our steadfast commitment to innovation, industrial transformation capabilities, and social responsibility.

Synaura channels its scientific prowessconfidence, actively advancing its nutrition leadership strategy to spearhead industrial chain development and drive the commercialisation of research outcomes. Our vision is to become an industry leader, propelling China's biosynthetic sector onto the global stage and contributing Chinese wisdom and strength to the advancement of worldwide biosynthetic technology!